Bannockburn, IL, July 18, 2010 --(PR.com
)-- Glycemion Strategies, Inc., an Illinois-based company that develops strategic initiatives for diabetic consumers and their professional health care providers, announced today the availability of a combination test specifically developed by Healthy Life Laboratories for diabetes and inflammation to serve the 150,000 dental professionals in the US and the millions of at-risk patients they serve.
“Until now, such testing would require a venous draw performed by a trained phlebotomist at a clinical laboratory, which is not practical for most dental professionals,” explained Henry Warner, CEO of Glycemion Strategies, Inc. “We contracted with microsampling industry leader, Healthy Life Laboratories to develop a convenient and accurate platform to collect fingernick blood which could be transported to and analyzed by a certified clinical laboratory,” added Warner.
Dr. Jack Maggiore, Chief Scientific Officer of Healthy Life Laboratories explains, “Two key underlying metabolic conditions that manifest in the oral cavity are diabetes and inflammation, and the biometric markers most appropriately used to screen for these conditions are Hemoglobin A1c (HbA1c) and high-sensitivity C-reactive protein (hs-CRP) respectively. Dental professionals need to assess the risk of these disorders before initiating any invasive procedures.”
Glycemion Strategies, Inc.
Glycemion Strategies, Inc. has served clients in the pharmaceutical, functional foods, nutraceutical and diagnostics industries in developing marketing strategies and implementing solutions. Its management team possesses over 65 combined years of experience in licensing and acquisitions, intellectual property, medical technologies, nutritional sciences, finance administration, marketing, operations, and regulatory affairs.
For additional information about Glycemion Strategies, Healthy Life Laboratories, or Healthy Heart Dentistry, contact Henry Warner at email@example.com or 847-236-0943, or visit www.healthylifelabs.com.